Mahana Therapeutics Raises $61 Million for Digital Therapeutics App

Naluri Hidup, a provider of online therapeutics and evidence-based interventions for chronic and preventive diseases, raised $1.1 million in seed funding. Investors include Duopharma Biotech Berhad, M Venture Partners, and RHL Ventures.

The company works by assessing a user’s health risk – based on the self-declared user information, such as gender, age, family history of chronic disease, cholesterol, blood pressure, blood sugar levels, and level of physical activity. The telehealth app connects with a doctor or a fitness coach.

Using its app, users can chat with health experts or even book telemedicine or in-person appointment. In addition to telemedicine services, the company also offers personalized digital fitness, wellness, and nutrition programs.

For its services, the company charges users between $45 monthly or $410 annually. The paid services include food journal, unlimited coaching, and face-to-face consultation sessions, and a 16-week behavior change coaching program, depending on the subscription plans.

“We see a trend of digital health moving beyond transactional telehealth consultations, to a different model of sustainable continuous care over longer periods, that delivers quantifiable and clinically-significant health outcomes,” said Mayank Parekh, Founding Partner of M Venture Partners.

Naluri plans to use the new funds to expand its telemedicine platform.

To date, the company has raised $1.5 million, including a $258,000 initial funding in 2018. Its existing investors include 500 Durians, Global Founders Capital, Stanford- Start X Fund, and BioMark.

Globally, telehealth companies raised $930 million in Q1 2020. The funding increased 244% in Q1 2020, compared to $270 million raised in the same quarter of last year (Q1 2019), according to Mercom Q1 2020 Digital Health Funding Report. Recently, Unmind, a provider of an online workplace mental health and wellness platform, raised $10 million in Series A funding. Project A led the round with additional participation from Felix Capital.